NP1398068.RAlRQTxcWgweSm-VPLf2qbRDD M0H5QZtAml-326itJS4
type: Nanopublication
has assertion: NP1398068.RAlRQTxcWgweSm-VPLf2qbRDD M0H5QZtAml-326itJS4130 assertion
has provenance: NP1398068.RAlRQTxcWgweSm-VPLf2qbRDD M0H5QZtAml-326itJS4130 provenance
has publication info: NP1398068.RAlRQTxcWgweSm-VPLf2qbRDD M0H5QZtAml-326itJS4130 publicationInfo
created: 2016-05-13T12:52:20+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP1398068.RAlRQTxcWgweSm-VPLf2qbRDD M0H5QZtAml-326itJS4130 assertion
type: Assertion
description: [Translocations involving a breakpoint cluster region of the MLL gene at chromosome band 11q23 are the most common molecular abnormalities in acute leukemias of infants and acute leukemias related to chemotherapy with DNA topoisomerase II inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/9639429
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0